Details
Stereochemistry | ACHIRAL |
Molecular Formula | C20H25N5O3S |
Molecular Weight | 415.509 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CC1=CC=C(CSCCNC2=NC(=O)C(CC3=CC(=O)NC=C3)=CN2)O1
InChI
InChIKey=MURUHMTVTKOWBY-UHFFFAOYSA-N
InChI=1S/C20H25N5O3S/c1-25(2)12-16-3-4-17(28-16)13-29-8-7-22-20-23-11-15(19(27)24-20)9-14-5-6-21-18(26)10-14/h3-6,10-11H,7-9,12-13H2,1-2H3,(H,21,26)(H2,22,23,24,27)
Molecular Formula | C20H25N5O3S |
Molecular Weight | 415.509 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Donetidine is a potent and long acting histamine H2-receptor antagonist with no H1-receptor antagonist activity. It is a highly basic drug with several amine groups. Donetidine stimulates the release of histamine when given by rapid intravenous infusion to dogs. Symptoms such as vasodilation, watering eye and nose, salivation and collapse, well known indicators of histamine release seen after administration of donetidine.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2469790
Curator's Comment: Dogs data
A single infusion of 2.5 mg/kg (0.5 ml/kg/min for 2 minutes). The treatments were given at 14-day intervals.
Route of Administration:
Intravenous
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:37:14 GMT 2023
by
admin
on
Fri Dec 15 15:37:14 GMT 2023
|
Record UNII |
E9730RXS4H
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29702
Created by
admin on Fri Dec 15 15:37:14 GMT 2023 , Edited by admin on Fri Dec 15 15:37:14 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
X-91
Created by
admin on Fri Dec 15 15:37:14 GMT 2023 , Edited by admin on Fri Dec 15 15:37:14 GMT 2023
|
PRIMARY | |||
|
C77439
Created by
admin on Fri Dec 15 15:37:14 GMT 2023 , Edited by admin on Fri Dec 15 15:37:14 GMT 2023
|
PRIMARY | |||
|
SUB06363MIG
Created by
admin on Fri Dec 15 15:37:14 GMT 2023 , Edited by admin on Fri Dec 15 15:37:14 GMT 2023
|
PRIMARY | |||
|
99248-32-5
Created by
admin on Fri Dec 15 15:37:14 GMT 2023 , Edited by admin on Fri Dec 15 15:37:14 GMT 2023
|
PRIMARY | |||
|
100000080781
Created by
admin on Fri Dec 15 15:37:14 GMT 2023 , Edited by admin on Fri Dec 15 15:37:14 GMT 2023
|
PRIMARY | |||
|
CHEMBL2104272
Created by
admin on Fri Dec 15 15:37:14 GMT 2023 , Edited by admin on Fri Dec 15 15:37:14 GMT 2023
|
PRIMARY | |||
|
DTXSID80912819
Created by
admin on Fri Dec 15 15:37:14 GMT 2023 , Edited by admin on Fri Dec 15 15:37:14 GMT 2023
|
PRIMARY | |||
|
6058
Created by
admin on Fri Dec 15 15:37:14 GMT 2023 , Edited by admin on Fri Dec 15 15:37:14 GMT 2023
|
PRIMARY | |||
|
C055237
Created by
admin on Fri Dec 15 15:37:14 GMT 2023 , Edited by admin on Fri Dec 15 15:37:14 GMT 2023
|
PRIMARY | |||
|
E9730RXS4H
Created by
admin on Fri Dec 15 15:37:14 GMT 2023 , Edited by admin on Fri Dec 15 15:37:14 GMT 2023
|
PRIMARY | |||
|
6917961
Created by
admin on Fri Dec 15 15:37:14 GMT 2023 , Edited by admin on Fri Dec 15 15:37:14 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |